Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Variants in Antiviral Genes are Risk Factors for Cognitive Decline and Dementia.

Licastro F, Raschi E, Carbone I, Porcellini E.

J Alzheimers Dis. 2015;46(3):655-63. doi: 10.3233/JAD-142718.

PMID:
25835418
2.

Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.

Costa AS, Agostini S, Guerini FR, Mancuso R, Zanzottera M, Ripamonti E, Racca V, Nemni R, Clerici M.

J Alzheimers Dis. 2017;60(3):1055-1063. doi: 10.3233/JAD-170520.

PMID:
28984602
3.

Herpes virus in Alzheimer's disease: relation to progression of the disease.

Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L, Licastro F.

Neurobiol Aging. 2014 Jan;35(1):122-9. doi: 10.1016/j.neurobiolaging.2013.06.024. Epub 2013 Aug 3.

PMID:
23916950
4.

A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.

Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, Pica F, Gonzalez O, Friedel CC, Barry G, Martin K, Craigon MH, Chen R, Kaza LN, Fossum E, Fazakerley JK, Efstathiou S, Volpi A, Zimmer R, Ghazal P, Haas J.

PLoS Pathog. 2013;9(8):e1003514. doi: 10.1371/journal.ppat.1003514. Epub 2013 Aug 8.

5.

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.

Martínez MF, Martín XE, Alcelay LG, Flores JC, Valiente JM, Juanbeltz BI, Beldarraín MA, López JM, Gonzalez-Fernández MC, Salazar AM, Gandarias RB, Borda SI, Marqués NO, Amillano MB, Zabaleta MC, de Pancorbo MM.

BMC Neurosci. 2009 Sep 30;10:125. doi: 10.1186/1471-2202-10-125.

6.

The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients.

Tumini E, Porcellini E, Chiappelli M, Conti CM, Beraudi A, Poli A, Caciagli F, Doyle R, Conti P, Licastro F.

Hum Psychopharmacol. 2007 Mar;22(2):75-80.

PMID:
17221831
7.

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.

Yip AG, Brayne C, Easton D, Rubinsztein DC; Medical Research Council Cognitive Function Ageing Study (MRC CFAS).

J Med Genet. 2002 Sep;39(9):639-43.

8.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991. Epub 2011 Jun 21.

PMID:
21701228
9.

Genetic determinants of "cognitive impairment, no dementia".

Dubé JB, Johansen CT, Robinson JF, Lindsay J, Hachinski V, Hegele RA.

J Alzheimers Dis. 2013;33(3):831-40. doi: 10.3233/JAD-2012-121477.

PMID:
23042215
11.

Interleukin 28B gene polymorphisms and Epstein-Barr virus-associated lymphoproliferative diseases.

Akay E, Patel M, Conibear T, Chaggar T, Haque T.

Intervirology. 2014;57(2):112-5. doi: 10.1159/000357326. Epub 2014 Jan 25.

12.

NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors.

Morris CM, Ballard CG, Allan L, Rowan E, Stephens S, Firbank M, Ford GA, Kenny RA, O'Brien JT, Kalaria RN.

Neurobiol Aging. 2011 Mar;32(3):554.e1-6. doi: 10.1016/j.neurobiolaging.2010.06.012. Epub 2010 Aug 5.

PMID:
20691505
13.

Association between apolipoprotein E gene polymorphism and Alzheimer's disease in Uighur and Han populations.

Zhou X, Miao H, Rausch WD, Long M, Luo X, Yu H, Zhang X, Bayahemaiti K, Abulizi P, Keyimu K.

Psychogeriatrics. 2012 Jun;12(2):83-7. doi: 10.1111/j.1479-8301.2011.00389.x.

14.

[Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].

Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.

Rev Neurol. 2004 May 1-15;38(9):801-7. Spanish.

15.

Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population.

Li Y, Shi Y, Chen J, Cai B, Ying B, Wang L.

Int J Immunogenet. 2012 Aug;39(4):346-52. doi: 10.1111/j.1744-313X.2012.01097.x. Epub 2012 Feb 10.

PMID:
22325058
16.

Epstein-Barr Virus and Human herpes virus 6 Type A DNA Enhance IL-17 Production in Mice.

Rahal EA, Hajjar H, Rajeh M, Yamout B, Abdelnoor AM.

Viral Immunol. 2015 Jun;28(5):297-302. doi: 10.1089/vim.2014.0129. Epub 2015 Apr 14.

PMID:
25870901
17.

Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.

Patel A, Rees SD, Kelly MA, Bain SC, Barnett AH, Thalitaya D, Prasher VP.

Neurosci Lett. 2011 Jan 7;487(2):144-8. doi: 10.1016/j.neulet.2010.10.010. Epub 2010 Oct 12.

PMID:
20946940
18.

The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE epsilon 4 carriers.

Wang M, Jia J.

Neurosci Lett. 2010 Oct 4;482(3):260-3. doi: 10.1016/j.neulet.2010.07.051. Epub 2010 Aug 1.

PMID:
20667498
19.

Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.

Qiu C, Winblad B, Fratiglioni L.

Neurol Res. 2006 Sep;28(6):650-6.

PMID:
16945218
20.

Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.

Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.

Dement Geriatr Cogn Disord. 2007;23(5):327-33. Epub 2007 Mar 19.

PMID:
17374951

Supplemental Content

Support Center